| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |